2016
DOI: 10.1002/cbic.201600302
|View full text |Cite
|
Sign up to set email alerts
|

Cationic DOPC–Detergent Conjugates for Safe and Efficient in Vitro and in Vivo Nucleic Acid Delivery

Abstract: The ability of a nonviral nucleic acid carrier to deliver its cargo to cells with low associated toxicity is a critical issue for clinical applications of gene therapy. We describe biodegradable cationic DOPC-C12 E4 conjugates in which transfection efficiency is based on a Trojan horse strategy. In situ production of the detergent compound C12 E4 through conjugate hydrolysis within the acidic endosome compartment was expected to promote endosome membrane destabilization and subsequent release of the lipoplexes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 54 publications
0
10
0
Order By: Relevance
“…Preparation of the cationic conjugates 1 and 6 has been described elsewhere (Pierrat et al, 2016a;Pierrat et al, 2016b). GL67 and formulation GL67A were prepared as reported in the literature (Chadwick et al, 1997;Griesenbach et al, 2011b).…”
Section: Synthesismentioning
confidence: 99%
See 2 more Smart Citations
“…Preparation of the cationic conjugates 1 and 6 has been described elsewhere (Pierrat et al, 2016a;Pierrat et al, 2016b). GL67 and formulation GL67A were prepared as reported in the literature (Chadwick et al, 1997;Griesenbach et al, 2011b).…”
Section: Synthesismentioning
confidence: 99%
“…Optimum conditions for in vitro DNA delivery with cationic lipid 1 to various cell lines were obtained at charge neutrality (N/P = 1) and without the need for addition of helper lipid (e.g. 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE) to improve transfection efficiency or decrease cytotoxicity (Pierrat et al, 2016a). Furthermore, the introduction of PEGylated lipids in the formulations led to significant loss in transfection efficiency in vitro (Fig.…”
Section: From In Vitro To In Vivo Transfectionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the course of our quest for nucleic acid carriers with improved transfection properties and safeness, we previously developed cationic derivatives of 1,2-dioleoyl- sn -glycero-3-phosphatidylcholine (DOPC), a major component of the cell membranes. These phosphotriester compounds proved highly efficient nucleic acid delivery reagents both in vitro (Pierrat et al, 2012 , 2013a , b ) and in vivo (Pierrat et al, 2016a , b , c ). This inspired us to develop erufosine-based biolabile phosphotriesters (pro-APLs) as dual gene delivery reagents for combined cancer therapy (Gaillard et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“… 4 The design of nanocarriers is thus of prime importance to maximize the amount of siRNA to be delivered into the cells. At the cellular level, examples of siRNA delivery systems include cationic polymers, 5 lipids, 6 peptides, 7 carbon nanotubes, 8 nanofibers 9 and micelles. 10 Although the latter systems are efficient and could behave in a synergistic fashion, 11 there is a lack of understanding on how the chemical structures of the cationic region (responsible for electrostatic interactions with the nucleic acids) impacts the overall transfection process, and a rationale is yet to be formulated.…”
Section: Introductionmentioning
confidence: 99%